Doxolipad
Country: Եվրոպական Միություն
language: դանիերեն
source: EMA (European Medicines Agency)
PAR
(PAR)
26-08-2019
documentation_request_body
documentation_request_send
documentation_request_send
active_ingredient:
doxorubicinhydrochlorid
MAH:
TLC Biopharmaceuticals B.V.
ATC_code:
L01DB01
INN:
doxorubicin
therapeutic_group:
Antineoplastiske midler
therapeutic_area:
Breast Neoplasms; Ovarian Neoplasms
therapeutic_indication:
Behandling af brystkræft og kræft i æggestokkene.
authorization_status:
nægtede
